No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis

The use of tumour necrosis factor (TNF) antagonists (infliximab [IFN], etanercept [ETN], adalimumab [ADA]) has changed the course of many rheumatic diseases, including rheumatoid arthritis (RA). However, some questions concerning their safety have emerged since their approval because they can trigge...

詳細記述

保存先:
書誌詳細
主要な著者: Benucci, Maurizio, Saviola, Gianantonio, Meacci, Francesca, Manfredi, Mariangela, Infantino, Maria, Campi, Paolo, Severino, Maurizio, Iorno, Miriam, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola
フォーマット: Artigo
言語:Inglês
出版事項: Bentham Open 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3793582/
https://ncbi.nlm.nih.gov/pubmed/24115967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312901307010075
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料